[{"address1": "830 Winter Street", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "857 399 9500", "website": "https://www.tscan.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "TScan Therapeutics, Inc., a clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company's lead product candidates include TSC-100 and TSC-101 for the treatment of patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and acute lymphoblastic leukemia (ALL) in patients undergoing allogeneic hematopoietic cell transplantation (HCT) is in Phase I clinical trial, as well as eliminates residual disease and promotes donor chimerism. It also advanced TS-102 into IND-enabling activities. In addition, the company develops TSC-200, TSC-201, TSC-202, TSC-203, and TSC-204, which are in Phase 1 clinical trial, for the treatment of solid tumors. It has collaboration agreements with Novartis Institutes for BioMedical Research, Inc. to discover and develop novel TCR-T therapies; and Amgen Inc. to identify antigens recognized by T cells in patients with Crohn's disease using TargetScan, a proprietary target discovery platform. TScan Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 208, "companyOfficers": [{"maxAge": 1, "name": "Dr. Gavin  MacBeath Ph.D.", "age": 54, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1025727, "exercisedValue": 0, "unexercisedValue": 207573}, {"maxAge": 1, "name": "Mr. Jason A. Amello CPA", "age": 56, "title": "CFO & Treasurer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 767342, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Chrystal U. Louis M.D., M.P.H.", "age": 48, "title": "Chief Medical Officer", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 550125, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen J. Elledge Ph.D.", "title": "Co-Founder & Chairman of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tomasz  Kula Ph.D.", "title": "Co-Founder & Member of Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Leiden  Dworak M.B.A.", "age": 40, "title": "Principal Accounting Officer", "yearBorn": 1984, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Justin  McCue Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Zoran  Zdraveski J.D., Ph.D.", "age": 54, "title": "Chief Legal & Strategy Officer and Company Secretary", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 657200, "exercisedValue": 0, "unexercisedValue": 85247}, {"maxAge": 1, "name": "Ms. Ann  Hargraves", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shrikanta  Chattopadhyay M.D.", "title": "Senior VP & Head of Translational Medicine", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.48, "open": 2.48, "dayLow": 2.285, "dayHigh": 2.5699, "regularMarketPreviousClose": 2.48, "regularMarketOpen": 2.48, "regularMarketDayLow": 2.285, "regularMarketDayHigh": 2.5699, "payoutRatio": 0.0, "beta": 0.992, "forwardPE": -1.9224807, "volume": 705591, "regularMarketVolume": 705591, "averageVolume": 394650, "averageVolume10days": 801070, "averageDailyVolume10Day": 801070, "bid": 2.45, "ask": 2.52, "bidSize": 2, "askSize": 2, "marketCap": 140735024, "fiftyTwoWeekLow": 1.02, "fiftyTwoWeekHigh": 6.225, "allTimeHigh": 14.71, "allTimeLow": 1.02, "priceToSalesTrailing12Months": 20.217644, "fiftyDayAverage": 1.8868, "twoHundredDayAverage": 1.819925, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 19390022, "profitMargins": 0.0, "floatShares": 44031335, "sharesOutstanding": 52471405, "sharesShort": 1567792, "sharesShortPriorMonth": 1711155, "sharesShortPreviousMonthDate": 1756425600, "dateShortInterest": 1759190400, "sharesPercentSharesOut": 0.0276, "heldPercentInsiders": 0.00228, "heldPercentInstitutions": 0.75487, "shortRatio": 5.99, "shortPercentOfFloat": 0.0336, "impliedSharesOutstanding": 56747993, "bookValue": 3.114, "priceToBook": 0.79640335, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -136775008, "trailingEps": -1.1, "forwardEps": -1.29, "enterpriseToRevenue": 2.786, "enterpriseToEbitda": -0.137, "52WeekChange": -0.5294118, "SandP52WeekChange": 0.13837254, "quoteType": "EQUITY", "currentPrice": 2.48, "targetHighPrice": 12.0, "targetLowPrice": 3.0, "targetMeanPrice": 8.57143, "targetMedianPrice": 9.0, "recommendationKey": "none", "numberOfAnalystOpinions": 7, "totalCash": 218044992, "totalCashPerShare": 3.842, "ebitda": -141123008, "totalDebt": 96700000, "quickRatio": 6.961, "currentRatio": 7.06, "totalRevenue": 6961000, "debtToEquity": 54.721, "revenuePerShare": 0.123, "returnOnAssets": -0.26773, "returnOnEquity": -0.63331, "grossProfits": -8573000, "freeCashflow": -82941872, "operatingCashflow": -126183000, "revenueGrowth": 4.739, "grossMargins": -1.23158, "ebitdaMargins": 0.0, "operatingMargins": -12.56599, "financialCurrency": "USD", "symbol": "TCRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "TScan Therapeutics, Inc.", "marketState": "CLOSED", "exchange": "NGM", "messageBoardId": "finmb_583057578", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "TScan Therapeutics, Inc.", "regularMarketChangePercent": 0.0, "regularMarketPrice": 2.48, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1626442200000, "postMarketChangePercent": -1.20968, "postMarketPrice": 2.45, "postMarketChange": -0.03, "regularMarketChange": 0.0, "regularMarketDayRange": "2.285 - 2.5699", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 394650, "fiftyTwoWeekLowChange": 1.46, "fiftyTwoWeekLowChangePercent": 1.4313726, "fiftyTwoWeekRange": "1.02 - 6.225", "fiftyTwoWeekHighChange": -3.745, "fiftyTwoWeekHighChangePercent": -0.6016064, "fiftyTwoWeekChangePercent": -52.941177, "earningsTimestamp": 1755144000, "earningsTimestampStart": 1762950600, "earningsTimestampEnd": 1762950600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.1, "epsForward": -1.29, "epsCurrentYear": -1.24957, "priceEpsCurrentYear": -1.9846827, "corporateActions": [], "postMarketTime": 1760744339, "regularMarketTime": 1760731200, "fiftyDayAverageChange": 0.59319997, "fiftyDayAverageChangePercent": 0.3143947, "twoHundredDayAverageChange": 0.66007507, "twoHundredDayAverageChangePercent": 0.36269358, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-16", "cryptoTradeable": false, "displayName": "TScan Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-10-18"}]